EUVIMEDEUVIMED entdecken
Scoping Review

Economics perspectives on understanding antimicrobial use and resistance: a scoping review from theory to practice

Katia Iskandar iD, Christine Roques, Pascale Salameh iD, Rana Rizk, Jalal Dahham iD, Mickaël Hiligsmann iD, Rita Karam, Laurent Molinier

Expert Review of Pharmacoeconomics & Outcomes Research · 2026

DOI: 10.1080/14737167.2025.2591291 ↗

Kurz gefasst

Scoping Review in der Zeitschrift Expert Review of Pharmacoeconomics & Outcomes Research, 2026. Verfasst von Katia Iskandar und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical Sciences, School of Pharmacy, Lebanese International University, Beirut, Lebanon. Hauptthemen laut MEDLINE: Antimicrobial Stewardship, Anti-Bacterial Agents, Drug Resistance, Microbial, Models, Economic. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 181 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

INTRODUCTION: Antimicrobial resistance (AMR) is a complex global health challenge with significant, yet underutilized economic dimensions. Beyond the clinical aspect, this growing threat demands interdisciplinary solutions that bridge economic theory and practice. AREAS COVERED: This scoping review synthesizes economic perspectives on AMR through systematic analysis from Ovid MEDLINE, Scopus, EconLit, and PubMed (December 2023 to June 2025). We examine four critical domains: (1) foundational economic theories explaining AMR drivers through public goods theory, tragedy of commons, externalities, and market failures; (2) real-world market dynamics including supply-demand imbalances and principal-agent relationships in clinical settings; (3) policy interventions spanning regulatory frameworks, fiscal measures, and behavioral economics applications in antimicrobial stewardship; and (4) economic evaluation methodologies encompassing descriptive, evaluative, and predictive analyses. Our analysis reveals how theoretical economic frameworks arise in healthcare practice and why comprehensive multi-component interventions outperform single-approach strategies. EXPERT OPINION: Sustainable AMR mitigation requires fundamentally rethinking policy design through these interconnected economic lenses, transitioning from fragmented interventions to economically coherent frameworks that align short-term clinical decisions with long-term antimicrobial preservation. These changes demand unprecedented collaboration between economists, clinicians, and policymakers to align individual incentives with collective health security.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antimicrobial StewardshipAnti-Bacterial AgentsDrug Resistance, MicrobialModels, EconomicAnti-Infective AgentsHumansHealth PolicyGlobal HealthDrug Resistance, Bacterial

Stichwörter der Autor:innen

Antimicrobial resistancebehavioral economicscomplexity economicseconomic theoryeconomics

Substanzen

Anti-Bacterial AgentsAnti-Infective Agents

Autor:innen und Institutionen

  • Department of Biomedical Sciences, School of Pharmacy, Lebanese International University, Beirut, Lebanon.
  • Faculty of Public Health-Section 2, Lebanese University, Fanar, Lebanon.
  • INSPECT-LB (Institut National de Santé Publique, d'Épidémiologie Clinique et de Toxicologie-Liban), Beirut, Lebanon.
  • Laboratoire de Génie Chimique, CNRS, INPT, UPS, Faculté de Pharmacie, Université de Toulouse, Toulouse, France.
  • Microbiology Department, Faculty of Pharmacy, ACM Pharma FONDEREPHAR, Toulouse, France.
  • Department of Primary Care and Population Health, University of Nicosia Medical School, Nicosia, Cyprus.

ORCID-Profile: Katia Iskandar, Pascale Salameh, Jalal Dahham, Mickaël Hiligsmann

Zitieren

APA

Iskandar, K., Roques, C., Salameh, P., Rizk, R., Dahham, J., Hiligsmann, M., Karam, R., & Molinier, L. (2026). Economics perspectives on understanding antimicrobial use and resistance: a scoping review from theory to practice. Expert Review of Pharmacoeconomics & Outcomes Research. https://doi.org/10.1080/14737167.2025.2591291

Vancouver

Iskandar K, Roques C, Salameh P, Rizk R, Dahham J, Hiligsmann M, et al. Economics perspectives on understanding antimicrobial use and resistance: a scoping review from theory to practice. Expert Review of Pharmacoeconomics & Outcomes Research. 2026. doi:10.1080/14737167.2025.2591291

BibTeX
@article{Iskandar2026,
  author = {Iskandar, Katia and Roques, Christine and Salameh, Pascale and Rizk, Rana and Dahham, Jalal and Hiligsmann, Mickaël and Karam, Rita and Molinier, Laurent},
  title = {Economics perspectives on understanding antimicrobial use and resistance: a scoping review from theory to practice},
  journal = {Expert Review of Pharmacoeconomics & Outcomes Research},
  year = {2026},
  doi = {10.1080/14737167.2025.2591291}
}
Kostenlos starten →